Sign in to add and modify your software
By joining Download.com, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy.
Please Note: This app is only for use by those participating in this study. The POINT 1 Study is a two part pediatric
study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.
The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation.